Physician profile
Michael D Poole
NPI 1376561142
$691.20
in general payments reported to CMS, 2019-2025
11 companies · $86.12 in 2025
The $86.12 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $89.71 · 2021: $103 · 2022: $90.43 · 2023: $115 · 2024: $90.29 · 2025: $86.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $170.29 | 2019-2022 | |
| Genzyme Corporation | $118.32 | 2021-2025 | |
| Glaxosmithkline, LLC. | $90.82 | 2021-2023 | Nucala |
| Medtronic, INC. | $88.88 | 2023-2025 | Bizact, Novapak, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $53.46 | 2022-2025 | Dupixent |
| Organogenesis INC. | $44.43 | 2022-2023 | Puraply |
| Optinose US, INC. | $36.85 | 2019-2020 | |
| Intersect Ent, INC. | $29.16 | 2021 | |
| Cochlear Americas | $20.39 | 2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Smith+Nephew, INC. | $19.53 | 2019 | |
| Alk-Abello, INC | $19.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Poole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.